DMAARDrugs Made In America Acquisition Corp. Rights

NAS · US · Financial Services · Diversified Financial Services

0.1475USD-1.67%Mkt Cap: —P/E: —3d ago

Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business …

Industry Peers

Diversified Financial Services

Screen all

CGCT

Cartesian Growth Corporation III Class A Ordinary Shares

$492.66MUSDP/E 39.7

NHIC

NewHold Investment Corp.

$293.25MUSD

FACT

Freedom Acquisition I Corp.

$259.75MUSDP/E 66.8

ISRL

Israel Acquisitions Corp Class A Ordinary Shares

$78.77MUSD

ROC

ROC Energy Acquisition Corp. Common Stock

$78.04MUSD

BPAC

Bullpen Parlay Acquisition Company Class A Ordinary Share

$75.18MUSDP/E 339.3

APLMW

Apollomics Inc. Warrant

$30.94MUSD

CNTM

ConnectM Technology Solutions Inc. Common Stock

$23.59MUSD

KAC-P

Kalon Acquisition Corp.

Climate Real Impact Solutions II Acquisition Corp

—

LATAW

Galata Acquisition Corp. II Warrant

—

BIOTW

Biotech Acquisition Company

—

CRGOW

Freightos Limited Warrants

—

KFIIR

K&F Growth Acquisition Corp. II Rights

—

BSAAR

BEST SPAC I Acquisition Corp. Rights

—

ALPXW

Alpex Acquisition Corporation Warrants

—

IEAGR

Infinite Eagle Acquisition Corp. Rights

Bleichroeder Acquisition Corp. III Warrant

—

Key Statistics

Company

Market Cap—

Enterprise Value—

Revenue (TTM)—

Gross Profit—

Net Income (TTM)6.66M $

Revenue/Share—

Last Price0.1475 USD

Fiscal Year End—

MR Quarter—

Employees—

CountryUS

SectorFinancial Services

IndustryDiversified Financial Services

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA—

EV/Revenue—

P/S—

P/B-0.67

EPS (TTM)—

EPS (Forward)—

52W Range

0.081656% of range0.2000

52W High0.2000 USD

52W Low0.0816 USD

Profitability

Gross Margin0.00%

Oper. Margin0.00%

EBITDA Margin0.00%

Profit Margin0.00%

ROE—

ROA—

Growth

Revenue Growth—

Earnings Growth18.80%

Cash Flow & Leverage

Operating CF-379.19K $

CapEx (TTM)—

FCF Margin—

FCF Yield—

Net Debt85.11K $

Net Debt/EBITDA—

Balance Sheet

Debt/Equity—

Current Ratio0.03

Quick Ratio0.03

Book Value/Sh-0.2150 USD

Cash/Share0.0000 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio—

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.20.40M

Float29.13M

Insiders—

Institutions—

Technical

SMA 50—

SMA 200—

Beta—

S&P 52W Chg18.16%

Avg Vol (30d)52.95K

Avg Vol (10d)—

Technical Indicators

RSI (14)48.9

MACD0.0054

MACD Signal0.0080

MACD Hist.-0.0026

BB Upper0.1710 USD

BB Middle0.1583 USD

BB Lower0.1456 USD

BB Width16.05%

ATR (14)0.0154 USD

Vol Ratio (20d)2.41x